11/20/2024
1:57 PM | Catalyst Pharmaceuticals (Subject)
MCENANY PATRICK J (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
11/15/2024
4:00 PM | Catalyst Pharmaceuticals (Issuer)
MCENANY PATRICK J (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
11/14/2024
8:55 AM | Catalyst Pharmaceuticals (Subject)
Flynn James E (Filed by)
| Form SC 13G/A | |
11/13/2024
4:44 PM | Catalyst Pharmaceuticals (Issuer)
MCENANY PATRICK J (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
11/12/2024
9:52 AM | Catalyst Pharmaceuticals (Subject)
MCENANY PATRICK J (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
11/06/2024
4:10 PM | Catalyst Pharmaceuticals (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
11/06/2024
3:08 PM | Catalyst Pharmaceuticals (Filer)
| Form 10-Q
General form for quarterly reports under Section 13 or 15(d) | |
|
10/18/2024
2:31 PM | BlackRock, Inc. (Filed by)
Catalyst Pharmaceuticals (Subject)
| Form SC 13G/A | |
10/17/2024
11:14 AM | Catalyst Pharmaceuticals (Subject)
STATE STREET CORP (Filed by)
| Form SC 13G/A | |
09/26/2024
7:42 AM | Catalyst Pharmaceuticals (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
08/23/2024
4:00 PM | Catalyst Pharmaceuticals (Issuer)
Tierney David S (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
08/22/2024
4:00 PM | Catalyst Pharmaceuticals (Issuer)
Miller Steve (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
08/21/2024
1:21 PM | Catalyst Pharmaceuticals (Subject)
Tierney David S (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
08/20/2024
3:42 PM | Catalyst Pharmaceuticals (Subject)
Miller Steve (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
08/19/2024
4:00 PM | Catalyst Pharmaceuticals (Issuer)
MCENANY PATRICK J (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
08/09/2024
1:53 PM | Catalyst Pharmaceuticals (Subject)
INGENITO GARY (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
08/09/2024
10:24 AM | Catalyst Pharmaceuticals (Subject)
Del Carmen Jeffrey (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
08/07/2024
3:32 PM | Catalyst Pharmaceuticals (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
07/26/2024
3:30 PM | Catalyst Pharmaceuticals (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
06/07/2024
10:17 AM | Catalyst Pharmaceuticals (Subject)
Del Carmen Jeffrey (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
06/05/2024
2:22 PM | Catalyst Pharmaceuticals (Subject)
INGENITO GARY (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
06/04/2024
9:41 AM | Catalyst Pharmaceuticals (Subject)
Daly Richard J (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
06/03/2024
11:22 AM | Catalyst Pharmaceuticals (Subject)
Harper Molly (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
05/31/2024
3:50 PM | Catalyst Pharmaceuticals (Filer)
| Form S-8
Registration statement under Securities Act of 1933 to be offered to employees pursuant to certain plans | |
05/31/2024
3:43 PM | Catalyst Pharmaceuticals (Filer)
| Form POS EX | |
05/31/2024
3:46 PM | Catalyst Pharmaceuticals (Filer)
| Form POS EX | |
05/31/2024
3:47 PM | Catalyst Pharmaceuticals (Filer)
| Form POS EX | |
05/30/2024
3:43 PM | Catalyst Pharmaceuticals (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
05/21/2024
4:28 PM | Catalyst Pharmaceuticals (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
04/10/2024
4:15 PM | Catalyst Pharmaceuticals (Issuer)
Tierney David S (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
04/10/2024
3:23 PM | Catalyst Pharmaceuticals (Filer)
| Form DEF 14A | |
04/10/2024
3:25 PM | Catalyst Pharmaceuticals (Filer)
| Form ARS | |
04/08/2024
1:03 PM | Catalyst Pharmaceuticals (Subject)
Tierney David S (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
03/28/2024
3:45 PM | Catalyst Pharmaceuticals (Issuer)
Elsbernd Brian (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
03/27/2024
2:01 PM | Catalyst Pharmaceuticals (Subject)
Elsbernd Brian (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
03/13/2024
4:01 PM | Catalyst Pharmaceuticals (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
02/28/2024
4:16 PM | Catalyst Pharmaceuticals (Filer)
| Form 10-K
Annual report pursuant to Section 13 or 15(d) | |
02/12/2024
4:31 PM | Catalyst Pharmaceuticals (Subject)
Flynn James E (Filed by)
| Form SC 13G/A | |
02/06/2024
4:00 PM | Catalyst Pharmaceuticals (Issuer)
DENKHAUS DONALD A (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
01/31/2024
4:01 PM | Catalyst Pharmaceuticals (Issuer)
MCENANY PATRICK J (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
01/25/2024
9:09 AM | Catalyst Pharmaceuticals (Subject)
STATE STREET CORP (Filed by)
| Form SC 13G/A | |
Trump’s IRS Hands Massive ‘Victory Gift’ To 401K Owners (Ad) Trump quietly left open an "off the books" wealth-protection loophole hidden in the 6,871 pages of the IRS Tax Code…
And since then…
"In the know" patriots have quietly used this same "Trump revenge loophole" to shield their life savings from Bidenomics… Get Your Free Gold Guide |
01/09/2024
4:15 PM | Catalyst Pharmaceuticals (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
01/08/2024
7:10 AM | Catalyst Pharmaceuticals (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
01/05/2024
4:23 PM | Catalyst Pharmaceuticals (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
01/05/2024
4:15 PM | Catalyst Pharmaceuticals (Filer)
| Form 424B5 | |
01/03/2024
4:18 PM | Catalyst Pharmaceuticals (Issuer)
Kalb Michael Wayne (Reporting)
| Form 3
Initial statement of beneficial ownership of securities | |
01/03/2024
4:18 PM | Catalyst Pharmaceuticals (Issuer)
Daly Richard J (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
01/03/2024
4:18 PM | Catalyst Pharmaceuticals (Issuer)
O'Keeffe Charles B (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
01/03/2024
4:19 PM | Catalyst Pharmaceuticals (Issuer)
Tierney David S (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
01/03/2024
4:19 PM | Catalyst Pharmaceuticals (Issuer)
MCENANY PATRICK J (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
12/29/2023
4:00 PM | Catalyst Pharmaceuticals (Issuer)
DENKHAUS DONALD A (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
12/29/2023
4:00 PM | Catalyst Pharmaceuticals (Issuer)
MCENANY PATRICK J (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
12/29/2023
4:00 PM | Catalyst Pharmaceuticals (Issuer)
Miller Steve (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
12/29/2023
4:00 PM | Catalyst Pharmaceuticals (Issuer)
GRANDE ALICIA (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
12/29/2023
4:00 PM | Catalyst Pharmaceuticals (Issuer)
INGENITO GARY (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
12/29/2023
4:00 PM | Catalyst Pharmaceuticals (Issuer)
Daly Richard J (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
12/29/2023
4:00 PM | Catalyst Pharmaceuticals (Issuer)
Del Carmen Jeffrey (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
12/29/2023
4:00 PM | Catalyst Pharmaceuticals (Issuer)
Tierney David S (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
12/29/2023
4:00 PM | Catalyst Pharmaceuticals (Issuer)
Harper Molly (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
12/29/2023
4:00 PM | Catalyst Pharmaceuticals (Issuer)
Sundaram Preethi (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
12/29/2023
4:00 PM | Catalyst Pharmaceuticals (Issuer)
O'Keeffe Charles B (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
12/29/2023
4:00 PM | Catalyst Pharmaceuticals (Issuer)
Elsbernd Brian (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
12/19/2023
4:00 PM | Catalyst Pharmaceuticals (Issuer)
Harper Molly (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
12/19/2023
3:30 PM | Catalyst Pharmaceuticals (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
12/15/2023
12:47 PM | Catalyst Pharmaceuticals (Subject)
Harper Molly (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
12/12/2023
4:00 PM | Catalyst Pharmaceuticals (Issuer)
Del Carmen Jeffrey (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
12/12/2023
4:00 PM | Catalyst Pharmaceuticals (Issuer)
Thompson Tamar (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
12/12/2023
4:00 PM | Catalyst Pharmaceuticals (Issuer)
Harper Molly (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
12/12/2023
4:00 PM | Catalyst Pharmaceuticals (Issuer)
Sundaram Preethi (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
12/12/2023
4:00 PM | Catalyst Pharmaceuticals (Issuer)
MCENANY PATRICK J (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
12/12/2023
4:00 PM | Catalyst Pharmaceuticals (Issuer)
DENKHAUS DONALD A (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
12/12/2023
4:00 PM | Catalyst Pharmaceuticals (Issuer)
Elsbernd Brian (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
12/12/2023
4:00 PM | Catalyst Pharmaceuticals (Issuer)
GRANDE ALICIA (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
12/12/2023
4:00 PM | Catalyst Pharmaceuticals (Issuer)
O'Keeffe Charles B (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
12/12/2023
4:00 PM | Catalyst Pharmaceuticals (Issuer)
Miller Steve (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
12/12/2023
4:00 PM | Catalyst Pharmaceuticals (Issuer)
Tierney David S (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
12/12/2023
4:00 PM | Catalyst Pharmaceuticals (Issuer)
INGENITO GARY (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
12/12/2023
1:21 PM | Catalyst Pharmaceuticals (Subject)
Tierney David S (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
12/11/2023
1:57 PM | Catalyst Pharmaceuticals (Subject)
GRANDE ALICIA (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
12/11/2023
11:54 AM | Catalyst Pharmaceuticals (Subject)
GRANDE ALICIA (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
12/08/2023
4:00 PM | Catalyst Pharmaceuticals (Issuer)
INGENITO GARY (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
12/08/2023
3:31 PM | Catalyst Pharmaceuticals (Filer)
| Form S-8
Registration statement under Securities Act of 1933 to be offered to employees pursuant to certain plans | |
12/08/2023
3:31 PM | Catalyst Pharmaceuticals (Filer)
| Form S-8
Registration statement under Securities Act of 1933 to be offered to employees pursuant to certain plans | |
12/07/2023
4:00 PM | Catalyst Pharmaceuticals (Issuer)
Miller Steve (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
12/07/2023
3:30 PM | Catalyst Pharmaceuticals (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
12/06/2023
11:48 AM | Catalyst Pharmaceuticals (Subject)
INGENITO GARY (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
12/05/2023
3:46 PM | Catalyst Pharmaceuticals (Subject)
Catalyst Pharmaceuticals (Subject)
Miller Steve (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
